John Thomas Dietz - Director, Eiger Biopharmaceuticals, Inc

As of April 12, 2021


John Thomas Dietz Net Worth

  • Net worth is estimated to be at least $398.51K
  • Owns at least 37,500 units of Eiger Biopharmaceuticals, Inc stock

John Thomas Dietz Trading

  • Largest purchase of shares was 4,000 units , worth over $55.76K on January 13, 2020
  • In total has made about 11 transactions over 5 years
  • Usually trades in March and April, with the busiest year in 2020 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

John Thomas Dietz Mailing Address

  • Mailing address is C/o Transcept Pharmaceutical, Inc. 1003 W. Cutting Blvd, Ste 110 Pt. Richmond CA 94804 CA

Eiger Biopharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David A. Cory 2020 $590,584 - - $829,564 $393,360 $16,671 $1,830,179
David A. Cory 2019 $565,833 - - $2,009,820 $285,000 $11,200 $2,871,853
Sriram Ryali 2020 $381,550 - - $234,442 $173,272 $12,296 $801,559
Sriram Ryali 2019 $335,000 - - $662,211 $117,250 $9,732 $1,124,193
Eldon Mayer 2020 $385,569 $100,000 $92,700 $1,199,520 $169,256 $2,328 $1,949,373
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1305253/000119312521137193/d146195ddef14a.htm

Eiger Biopharmaceuticals, Inc Insider Trading

  • The most recent transaction was 2,500 units bought on April 12, 2021 by John Thomas Dietz worth over $21.22K
  • In the last 5 years, insiders at Eiger Biopharmaceuticals, Inc sold an estimated value of $2.94M and bought an estimated value of $4.61M
  • The most active traders are John Thomas Dietz, Director,  David Cory, President and CEO,  and Eldon Mayer III, Ex VP & Chief Commerc. Officer
  • Insider trading is most common in March, with the busiest year in 2019

Eiger BioPharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1